EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling

Jesse A Pace, Lauren M Goddard, Courtney C Hong, Liqing Wang, Jisheng Yang, Mei Chen, Yitian Xu, Martin H Dominguez, Siqi Gao, Xiaowen Chen, Patricia Mericko-Ishizuka, Can Tan und 6 weitere

Journal of Clinical Investigation · 16.06.2025 · 135 (12)

DOI: 10.1172/jci186593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.06.2025. Verfasst von Jesse A Pace und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Institute, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Hemodynamics, Heart Valve Diseases, Signal Transduction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myxomatous valve disease (MVD) is the most common form of cardiac valve disease in the developed world. A small fraction of MVD is syndromic and arises in association with matrix protein defects such as those in Marfan syndrome, but most MVD is acquired later in life through an undefined pathogenesis. The KLF2/4 transcription factors mediate endothelial fluid shear responses, including those required to create cardiac valves during embryonic development. Here we test the role of hemodynamic shear forces and downstream endothelial KLF2/4 in mature cardiac valves. We find that loss of hemodynamic forces in heterotopically transplanted hearts or genetic deletion of KLF2/4 in cardiac valve endothelium confers valve cell proliferation and matrix deposition associated with valve thickening, findings also observed in mice expressing the mutant fibrillin-1 protein known to cause human MVD. Transcriptomic and histologic analysis reveals increased monocyte recruitment and TGF-β signaling in both fibrillin-1–mutant valves and valves lacking hemodynamic forces or endothelial KLF2/4 function, but only loss of TGF-β/SMAD signaling rescued myxomatous changes. We observed reduced KLF2/4 expression and augmented SMAD signaling in human MVD. These studies identify hemodynamic activation of endothelial KLF2/4 as an environmental homeostatic regulator of cardiac valves and suggest that non-syndromic MVD may arise in association with disturbed blood flow across the aging valve.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kruppel-Like Transcription FactorsHemodynamicsHeart Valve DiseasesSignal TransductionAnimalsKruppel-Like Factor 4MiceHumansFibrillin-1Mice, KnockoutTransforming Growth Factor betaAdipokines

Stichwörter der Autor:innen

CardiologyCardiovascular diseaseEndothelial cellsVascular biology

Substanzen

Kruppel-Like Factor 4Klf4 protein, mouseKruppel-Like Transcription FactorsKlf2 protein, mouseFibrillin-1Fbn1 protein, mouseKLF4 protein, humanTransforming Growth Factor betaKLF2 protein, humanAdipokines

Autor:innen und Institutionen

  • Cardiovascular Institute, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Transplant Immunology, Department of Pathology and Laboratory Medicine, and Biesecker Center for Pediatric Liver Disease, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pen…
  • Department of Medicine, Feinberg Cardiovascular and Renal Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Division of Oncology and Center for Childhood Cancer Research, Center for Single Cell Biology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Surgery, Department of Biomedical Engineering, Columbia University, New York, New York, USA.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Pace, J. A., Goddard, L. M., Hong, C. C., Wang, L., Yang, J., Chen, M., Xu, Y., Dominguez, M. H., Gao, S., Chen, X., Mericko-Ishizuka, P., Tan, C., Kume, T., Yu, W., Tan, K., Hancock, W. W., Ferrari, G., & Kahn, M. L. (2025). Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling. Journal of Clinical Investigation, 135(12). https://doi.org/10.1172/jci186593

Vancouver

Pace JA, Goddard LM, Hong CC, Wang L, Yang J, Chen M, et al. Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling. Journal of Clinical Investigation. 2025;135(12). doi:10.1172/jci186593

BibTeX
@article{Pace2025,
  author = {Pace, Jesse A and Goddard, Lauren M and Hong, Courtney C and Wang, Liqing and Yang, Jisheng and Chen, Mei and Xu, Yitian and Dominguez, Martin H and Gao, Siqi and Chen, Xiaowen and Mericko-Ishizuka, Patricia and Tan, Can and Kume, Tsutomu and Yu, Wenbao and Tan, Kai and Hancock, Wayne W and Ferrari, Giovanni and Kahn, Mark L},
  title = {Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {12},
  doi = {10.1172/jci186593}
}
Kostenlos starten →